Question

Difficulty: MediumPulmonary and Critical Care

A 62-year-old woman with a history of chronic obstructive pulmonary disease (COPD) presents to the emergency department complaining of progressive shortness of breath over the past three days. She reports an increased frequency of cough and a change in her sputum from clear to thick and yellow-green. She denies chest pain, orthopnea, or paroxysmal nocturnal dyspnea. Her daily medications include a long-acting muscarinic antagonist and a short-acting beta-agonist as needed. Vital signs are temperature 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), blood pressure 135/85 mmHg135/85\text{ mmHg}, heart rate 108/min108\text{/min}, and respiratory rate 26/min26\text{/min}. Oxygen saturation is 86%86\% on room air.

Physical examination reveals a patient in moderate respiratory distress, using accessory muscles of respiration. Auscultation demonstrates a prolonged expiratory phase and diffuse end-expiratory wheezing bilaterally. Cardiac examination shows a rapid, regular rhythm with no murmurs, gallops, or jugular venous distention. There is no peripheral edema.

Chest radiograph shows hyperinflated lung fields with flattened diaphragms, but no focal consolidations or pleural effusions.

Arterial blood gas on room air reveals:
pH: 7.287.28
PaCO2\text{PaCO}_2: 66 mmHg66\text{ mmHg}
PaO2\text{PaO}_2: 54 mmHg54\text{ mmHg}
HCO3−\text{HCO}_3^-: 30 mEq/L30\text{ mEq/L}

Which of the following are appropriate next steps in the management of this patient? (Select all that apply)

  1. Initiate noninvasive positive pressure ventilationAnswer
  2. Administer systemic glucocorticoidsAnswer
  3. C
    Administer intravenous furosemide
  4. D
    Initiate empiric intravenous vancomycin and cefepime
  5. E
    Calculate expected respiratory compensation using Winter's formula

Answer

The correct steps are to initiate noninvasive positive pressure ventilation (NPPV) and administer systemic glucocorticoids.
The patient is experiencing a severe acute exacerbation of COPD, evidenced by worsening dyspnea, increased sputum volume, and sputum purulence. Her arterial blood gas demonstrates acute-on-chronic respiratory acidosis (pH <7.35< 7.35 and PaCO2>45 mmHg\text{PaCO}_2 > 45\text{ mmHg}). This specific acid-base derangement in a COPD patient is a primary indication for noninvasive positive pressure ventilation (NPPV), which decreases the work of breathing, improves gas exchange, and reduces the need for endotracheal intubation. Concurrently, systemic glucocorticoids (e.g., oral prednisone or intravenous methylprednisolone) are standard of care for all moderate-to-severe COPD exacerbations to reduce airway inflammation, shorten recovery time, and improve lung function.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient is experiencing an acute exacerbation of COPD characterized by increased dyspnea, increased sputum volume, and sputum purulence.
Recognizing the cardinal symptoms of COPD exacerbation guides both respiratory and pharmacological management.
2
Analyze the arterial blood gas (ABG).
pH of 7.28 and PaCO2 of 66 mmHg indicate a primary respiratory acidosis. The elevated HCO3- (30 mEq/L) reflects partial metabolic compensation.
Determining the acid-base status is necessary to decide on the appropriate level of respiratory support.
3
Determine the indications for respiratory support.
Because the pH is below 7.35 due to hypercapnia, noninvasive positive pressure ventilation (NPPV) is strongly indicated.
NPPV has been shown to decrease mortality, reduce the need for endotracheal intubation, and improve pH and PaCO2 in severe COPD exacerbations.
4
Select appropriate medical therapy.
In addition to bronchodilators and targeted antibiotics (for purulent sputum), systemic glucocorticoids are required.
Systemic glucocorticoids decrease airway inflammation, improve forced expiratory volume in 1 second (FEV1), and reduce the risk of relapse.

Key Concept

Management of acute exacerbation of COPD with acute-on-chronic respiratory acidosis
Rate this question